Open access
Sep 2026
Core Outcome Set Measures Are Underreported in Breast Cancer Randomized Clinical Trials: A Cross-Sectional Study.
INTRODUCTION Randomized controlled trials (RCTs) are the gold standard in oncology for the discovery of new therapeutic approaches and treatment management. As medicine takes a more patient-centered approach, patient-reported outcomes (PROs) have become imperative, particularly in clinical trials. The need for standard...
A. Douglas, Ty Moore, Griffin K. Hughes et al.
· Clinical Breast Cancer · 0 citations